Viewing nowCombinationBiswon Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 201600976 · Approved 2016.02.22
This product's status changed to Expired on 2026.02.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (such as ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
This medication is used for conditions related to the stomach and duodenum, including ulcers, gastritis, and gastroesophageal reflux disease. It is also helpful in treating disorders associated with excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It is utilized for the prevention of Mendelson's syndrome prior to anesthesia and is effective for treating ulcers that may occur post-surgery. It is used for gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). It is applied in the treatment of various gastrointestinal diseases to alleviate symptoms.
Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant treatment to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose if needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used in patients undergoing dialysis or those who have had allergic reactions to it. It is also unsafe for patients with a history of acute porphyria, those with impaired kidney function, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants and newborns, and patients with potassium intake restrictions. Patients with compromised liver function or previous experiences of drug allergies, elderly patients, and patients with a history of kidney disease should use this medication with caution. Patients with gastric ulcers or recently developed dyspeptic symptoms should be checked for malignancy before use, as this medication may mask the symptoms of gastric cancer. Patients with Helicobacter pylori infection along with gastric and duodenal ulcers should undergo eradication therapy; other patients, especially those who are critically ill or have hypophosphatemia, may also require caution. While using this medication, various side effects such as shock, severe allergic reactions, skin rashes, blood abnormalities, liver dysfunction, arrhythmias, digestive symptoms, neurological disturbances, muscle pain may occur, so if any abnormal symptoms are observed, discontinue use immediately and consult a doctor. Avoid long-term use, and if there is no therapeutic effect, consider switching to a different medication. Caution is necessary as there may be an increased risk of pneumonia in elderly patients or those with chronic lung disease, diabetes, and impaired immunity. Patients should avoid driving or operating dangerous machinery if dizziness or drowsiness occurs. This medication may interact with other drugs, so consult with a doctor or pharmacist if taking other medications, especially antacids should be taken with an interval. It is safest for pregnant or nursing women not to use this medication, and it is preferable not to administer it to children. Furthermore, this medication may cause false-positive results in urine protein tests, so caution is necessary during testing. In cases of overdose, emergency treatment such as vomiting or gastric lavage may be needed, and blood dialysis may also be considered. Lastly, this medication may reduce gastric acid secretion, leading to an increase in bacterial growth in the gastrointestinal tract, and long-term use may require ocular examinations.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage helps to maintain the drug’s effectiveness for a longer period.
Green round film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.